×
For best experience we recommend to activate Javascript in your browser.
LGALS8 antibody (AA 151-316)
The Rabbit Polyclonal anti-LGALS8 antibody (ABIN7617886) specifically detects LGALS8 in WB, IHC, ICC and IP.
The antibody is reactive with Rat samples.
Catalog No. ABIN7617886
$479.17
Plus shipping costs $50.00
Delivery in 2 to 4 Business Days
Quick Overview for LGALS8 antibody (AA 151-316) (ABIN7617886)
Target
See all LGALS8 Antibodies
LGALS8
(Lectin, Galactoside-Binding, Soluble, 8 (LGALS8))
Reactivity
All reactivities for LGALS8 antibodies
Rat
Host
All hosts for LGALS8 antibodies
Rabbit
Clonality
All clonalities for LGALS8 antibodies
Polyclonal
Conjugate
All conjugates for LGALS8 antibodies
This LGALS8 antibody is un-conjugated
Application
All applications for LGALS8 antibodies
Western Blotting (WB), Immunohistochemistry (IHC), Immunocytochemistry (ICC), Immunoprecipitation (IP)
Product Details anti-LGALS8 Antibody
(hide)
Binding Specificity
All epitopes for LGALS8 antibodies
AA 151-316
Purpose
Galectin 8 (GAL8) Polyclonal Antibody
Sequence
Arg151~Trp316
Characteristics
The Galectin 8 (GAL8) Polyclonal Antibody (Species: Rat) has been validated for the following applications: WB, IHC, ICC, IP.
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Concentration
0.5 mg/mL
Buffer
PBS, pH 7.4, containing 0.02 % Sodium azide, 50 % glycerol
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Storage Comment
2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
Expiry Date
12 months
Target Details for LGALS8
(hide)
Target
LGALS8
(Lectin, Galactoside-Binding, Soluble, 8 (LGALS8))
Alternative Name
GAL8
UniProt
Q62665
Recently viewed
(hide)
Chat with us , powered by LiveChat